Publications :: Propanc Biopharma, Inc. (PPCB)

Blocking Tumor Support from Cancer-Associated Fibroblasts in Tumor Microenvironment

María Belén Toledo Cutillas, Juan Antonio Marchal Corrales, Macarena Perán Quesada

Trypsinogen and chymotrypsinogen: potent anti- tumor agents

Aitor González-Titos, Pablo Hernández-Camarero, Shivan Barungi, Juan Antonio Marchal, Julian Kenyon & Macarena Perán

Full article: Trypsinogen and chymotrypsinogen: potent anti-tumor agents (tandfonline.com) »

Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting

Pablo Hernández-Camarero, Elena López-Ruiz, Carmen Griñán-Lisón, María Ángel García, Carlos Chocarro-Wrona, Juan Antonio Marchal, Julian Kenyon & Macarena Perán

The publication is available at nature.com »

Antitumour efficacy of chymotrypsinogen and trypsinogen

P. Hernández, E. López-Ruiz, M. A. García, J. A. Marchal, J. Kenyon, M. Perán*

Learn More »

In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation

Macarena Perán, Juan Antonio Marchal, Maria A. García, Julian Kenyon & David Tosh

The publication is available at link.springer.com »

A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer

Macarena Perán, Elena López-Ruiz, María Ángel García, Shorena Nadaraia-Hoke, Ralf Brandt, Juan A. Marchal & Julian Kenyon